Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.79M

combined est. value

Stock	Shares	Price	Value	Weight	As of
XERSXeris Biopharma Holdings, Inc.	219,188	$8.08	$1.77M	99%	2025-08-28
LRMRLarimar Therapeutics, Inc.	5,000	$4.10	$20.5K	1%	2026-02-27

XERS

Xeris Biopharma Holdings, Inc.

$1.77M

219,188 sh

LRMR

Larimar Therapeutics, Inc.

$20.5K

5,000 sh

Activity

Open-market buy & sell volume

BuySell

Total +$25.0K bought · −$334.5K sold

Most bought

LRMR

$25.0K

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 1sells 1

Stock	Transaction	Date	~6mo later
LRMRLarimar Therapeutics, Inc.	Buy $25.0K · 5,000 sh	2026-02-27	in progress
XERSXeris Biopharma Holdings, Inc.	Sell $334.5K · 42,232 sh	2025-08-28	—
XERSXeris Biopharma Holdings, Inc.	Exercise $313.3K · 47,040 sh	2025-08-28	—
XERSXeris Biopharma Holdings, Inc.	Grant — · 50,000 sh	2025-06-04	—

LRMRBuy

2026-02-27 · Larimar Therapeutics, Inc.

$25.0K

in progress

XERSSell

2025-08-28 · Xeris Biopharma Holdings, Inc.

$334.5K

—

XERSExercise

2025-08-28 · Xeris Biopharma Holdings, Inc.

$313.3K

—

XERSGrant

2025-06-04 · Xeris Biopharma Holdings, Inc.

50,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.